Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates

Author's Avatar
May 15, 2023

Spruce+Biosciences%2C+Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today reported financial results for the quarter ended March 31, 2023 and provided corporate updates.